August 8th, 2016: Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis
Jody Smith joins with other ME voices in honor of Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis.
Discuss the article on the Forums.

Prothena Announces First Human Dosed in Phase 1 Study of PRX003 (Treatment of Inflammatory Diseases)

Discussion in 'Other Health News and Research' started by Bob, Jun 10, 2015.

  1. Bob

    Bob

    Messages:
    10,703
    Likes:
    34,252
    England (south coast)
    It's only news about a phase 1 study (for a monoclonal antibody) which means that the drug is more than likely never to reach the market, but i thought it might be of interest for some people anyway...

    Prothena Announces First Human Dosed in Phase 1 Study of PRX003 for the Treatment of Psoriasis and Other Inflammatory Diseases

    June 9 2015
    http://money.cnn.com/news/newsfeeds/articles/globenewswire/10137588.htm

     
    rosie26 and alex3619 like this.

See more popular forum discussions.

Share This Page